Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Stephen Chan, Kay Friedrichs, D. Noel et al. · Journal of Clinical Oncology · 1999 · 638 citations

Medicine, Oncology, Pharmacology +16

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

Medicine, Oncology, Pharmacology +12

Advanced breast cancer: a phase II trial with gemcitabine.

J Carmichael, K. Possinger, P. Phillip et al. · Journal of Clinical Oncology · 1995 · 338 citations

Medicine, Oncology, Pharmacology +13

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

J Sjöström, Carl Blomqvist, Henning T. Mouridsen et al. · European Journal of Cancer · 1999 · 269 citations

Medicine, Oncology, Pharmacology +16

Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer

Harold J. Burstein, Judith Manola, Jerry Younger et al. · Journal of Clinical Oncology · 2000 · 261 citations

Medicine, Oncology, Pharmacotherapy +16